Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

CUSIP: 75915K309

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
+36,451,747
Put/Call ratio
5.3%
SEC-reported price per share
$2.88
Number of holders
42
Value change
+$103,077,800
Number of buys
34
Open additional details 1 more signal available
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
66,505,186

Security key

75915K309

Report period

Q1 2024

Institutions

42

Top holders

10

Ownership snapshot

Top reported holders of RGLS - Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
42
Shares
45,620,114
Rows available
42
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
42
Q1 2024 holders
42
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .